false 0001551152 Common Stock, $0.01 Par Value ABBV 0001551152 2024-12-11 2024-12-11 0001551152 us-gaap:CommonStockMember exch:XNYS 2024-12-11 2024-12-11 0001551152 exch:XCHI us-gaap:CommonStockMember 2024-12-11 2024-12-11 0001551152 abbv:SeniorNotes0.750Percentdue2027Member exch:XNYS 2024-12-11 2024-12-11 0001551152 abbv:SeniorNotes2.125Percentdue2028Member exch:XNYS 2024-12-11 2024-12-11 0001551152 abbv:SeniorNotes2.625Percentdue2028Member exch:XNYS 2024-12-11 2024-12-11 0001551152 abbv:SeniorNotes2.125Percentdue2029Member exch:XNYS 2024-12-11 2024-12-11 0001551152 abbv:SeniorNotes1.250Percentdue2031Member exch:XNYS 2024-12-11 2024-12-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): December 11, 2024

 

ABBVIE INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-35565   32-0375147
(State or other Jurisdiction
of Incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

 

 

 

1 North Waukegan Road

North Chicago, Illinois 60064-6400

(Address of principal executive offices)(Zip Code) 

 

Registrant’s telephone number, including area code: (847) 932-7900

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.01 Par Value   ABBV   New York Stock Exchange
Chicago Stock Exchange
0.750% Senior Notes due 2027   ABBV27   New York Stock Exchange
2.125% Senior Notes due 2028   ABBV28   New York Stock Exchange
2.625% Senior Notes due 2028   ABBV28B   New York Stock Exchange
2.125% Senior Notes due 2029   ABBV29   New York Stock Exchange
1.250% Senior Notes due 2031   ABBV31   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On December 11, 2024, Kevin K. Buckbee, Senior Vice President, Controller, informed AbbVie that he plans to retire from the Controller role effective March 1, 2025. David R. Purdue, 47, has been appointed Senior Vice President, Controller effective March 1, 2025 (the “Effective Date”). Mr. Purdue has been AbbVie’s Vice President, Controller, Commercial Operations since 2022.  Mr. Purdue previously served as AbbVie’s Vice President, Treasurer; Vice President, Financial Planning and Analysis; and Vice President, Finance Integration Lead, among other finance organization roles at AbbVie and Abbott Laboratories, AbbVie’s former parent company.  Mr. Purdue joined Abbott Laboratories in 2003.

 

As of the Effective Date, Mr. Purdue’s annual base salary will be $550,000. Mr. Purdue will be eligible to participate in AbbVie’s Performance Incentive Plan or any successor annual bonus plan with a target bonus equal to 85% of his base salary, subject to the attainment of one or more pre-established performance targets.

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  ABBVIE INC.
   
Date: December 13, 2024 By: /s/ Timothy J. Richmond
    Timothy J. Richmond
    Executive Vice President, Chief Human Resources Officer

 

 

 

v3.24.3
Cover
Dec. 11, 2024
Document Information [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Dec. 11, 2024
Entity File Number 001-35565
Entity Registrant Name ABBVIE INC.
Entity Central Index Key 0001551152
Entity Tax Identification Number 32-0375147
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 1 North Waukegan Road
Entity Address, City or Town North Chicago
Entity Address, State or Province IL
Entity Address, Postal Zip Code 60064-6400
City Area Code 847
Local Phone Number 932-7900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, $0.01 Par Value
Trading Symbol ABBV
Security Exchange Name NYSE
Common Stock [Member] | NYSE CHICAGO, INC. [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock, $0.01 Par Value
Trading Symbol ABBV
Security Exchange Name CHX
Senior Notes 0.750 Percent due 2027 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]  
Document Information [Line Items]  
Title of 12(b) Security 0.750% Senior Notes due 2027
Trading Symbol ABBV27
Security Exchange Name NYSE
Senior Notes 2.125 Percent due 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]  
Document Information [Line Items]  
Title of 12(b) Security 2.125% Senior Notes due 2028
Trading Symbol ABBV28
Security Exchange Name NYSE
Senior Notes 2.625 Percent due 2028 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]  
Document Information [Line Items]  
Title of 12(b) Security 2.625% Senior Notes due 2028
Trading Symbol ABBV28B
Security Exchange Name NYSE
Senior Notes 2.125 Percent due 2029 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]  
Document Information [Line Items]  
Title of 12(b) Security 2.125% Senior Notes due 2029
Trading Symbol ABBV29
Security Exchange Name NYSE
Senior Notes 1.250 Percent due 2031 [Member] | NEW YORK STOCK EXCHANGE, INC. [Member]  
Document Information [Line Items]  
Title of 12(b) Security 1.250% Senior Notes due 2031
Trading Symbol ABBV31
Security Exchange Name NYSE
Grafico Azioni AbbVie (NYSE:ABBV)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di AbbVie
Grafico Azioni AbbVie (NYSE:ABBV)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di AbbVie